NCT05182385: Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 30 taking part
- Started
- 15 Dec 2021
- Primary completion
- 30 Apr 2026
- Arms
- hematological relapse, molecular relapse
- Results
- None posted
- 15 Dec 2021: Trial started
- 10 Jan 2022: Trial registered